Applications of polymeric nanocapsules in field of drug delivery systems

Current Drug Discovery Technologies

Volumn 8, Issue 3, 2011, Pages 173-187

  Rong, Xinyu ^a   Xie, Yinghua ^a   Hao, Xiaomei ^a   Chen, Tao ^a   Wang, Yingming ^a   Liu, Yuanyuan ^a  

^a HEBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Applications; Characterization; Delivery; Nanocapsules; Polymeric materials; Preparations

Indexed keywords

NANOCAPSULE; POLYMER;

ARTICLE; BIOAVAILABILITY; BIODEGRADABILITY; CONTROLLED DRUG RELEASE; DIFFUSION; DRUG DELIVERY SYSTEM; EMULSION; ENCAPSULATION; MORPHOLOGY; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; SURFACE PROPERTY; THICKNESS;

ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; HUMANS; NANOCAPSULES; PARTICLE SIZE; POLYMERS;

EID: 80051991351     PISSN: 15701638     EISSN: 18756220     Source Type: Journal    
DOI: 10.2174/157016311796799008     Document Type: Article

References (149)

1. Preetz C, Rübe A, Reiche ID, Hause G, Mäder K. Preparation and characterization of biocompatible oil-loaded polyelectrolyte nanocapsules. Nanomedicine NBM 2008;4:106-14.
2. Quintanar-Guerrero D, Allémann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm 1998;24(12):1113-28. (Pubitemid 28546092)
3. Letchford K, Burt H. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm 2007;65:259-69. (Pubitemid 46321600)
4. Agarwal A, Lvov Y, Sawant R, Torchilin V. Stable nanocolloids of poorly soluble drugs with high drug content prepared using the combination of sonication and layer-by-layer technology. J Control Release 2008;128:255-60.
5. Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 1989;55:R1-R4. (Pubitemid 19247505)
6. Devissaguet JP, Fessi H, Puisieux F. Process for the preparation of dispersible colloidal systems of a substance in the form of nanocapsules. US Patent 5, 049, 322, September 17, 1999.
7. Chen YF, Lin XF, Park H, Greever R. Study of artemisinin nanocapsules as anticancer drug delivery systems. Nanomedicine 2009;3:316-22.
8. Khoee S, Yaghoobian M. An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-G in double emulsion. Eur J Med Chem 2009;44(6):2392-9.
9. Furtado VC, Legrand P, Gulik A, et al. Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. Biomaterials 2001;22:2967-79. (Pubitemid 32768704)
10. Furtado VC, Legrand P, Morgat JL, et al. Biodistribution of longcirculating PEG-grafted nanocapsules in mice: effects of PEG chain length and density. Pharm Res 2001;18:1411-9. (Pubitemid 32977246)
11. Ourique AF, Pohlmann AR, Guterres SS, Beck RCR. Tretionoinloaded nanocapsules: preparation, physicochemical characterization, and photostability study. Int J Pharm 2008;352:1-4.
12. Guinebretière S, Briancon S, Fessi H, Teodorescu VS, Blanchin MG. Nanocapsules of biodegradable polymers: preparation and characterization by direct high resolution electron microscopy. Mater Sci Eng C 2002;21:137-42.
13. Pinto C, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine: NBM 2006;2:8-21.
14. Anton N, Benoit JP, Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates-a review. J Control Release 2008;128:185-99.
15. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res 1998;15(9):1326-31. (Pubitemid 28427917)
16. Santander-Ortega MJ, Lozano-López MV, Bastos-González D, Peula-García JM, Ortega-Vinuesa JL. Novel core-shell lipidchitosan and lipid-poloxamer nanocapsules: stability by hydration forces. Colloid Polym Sci 2010;288:159-72.
17. Chang SC, Rowley JA, Tobias G, et al. Injection molding of chondrocyte/alginate constructs in the shape of facial implants. J Biomed Mater Res 2001;55(4):503-11. (Pubitemid 32336280)
18. Cirone P, Bourgeois JM, Austin RC, Chang PL. A novel approach to tumor suppression with microencapsulated recombinant cells. Hum Gene Ther 2002;13(10):1157-66. (Pubitemid 34746696)
19. Rhazi M, Desbrieres J, Tolaimate A, et al. Influence of the nature of the metal ions on the complexation with chitosan. Application to the treatment of liquid waste. Eur Polym J 2002;38(8):1523-30. (Pubitemid 34544951)
20. Kim SK, Park PJ, Yang HP, Han SS. Subacute toxicity of chitosan oligosaccharide in Sprague-Dawley rats. Arzneimittelforschung 2001;51(9):769-74.
21. Rao SB, Sharma CP. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res 1997;34(1):21-8. (Pubitemid 26425214)
22. Joki T, Machluf M, Atala A, et al. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat Biotechnol 2001;19(1):35-9. (Pubitemid 32051953)
23. Shang Q, Wang Z, Liu W, Shi Y, Cui L, Cao Y. Tissue-engineered bone repair of sheep cranial defects with autologous bone marrow stromal cells. J Craniofac Surg 2001;12(6):586-93. (Pubitemid 34873930)
24. Thomas S. Alginate dressings in surgery and wound management-Part 1. J Wound Care 2000;9(2):56-60.
25. Sikorski P, Mo F, Skjak-Braek G, Stokke BT. Evidence for eggbox-compatible interactions in calcium-alginate gels from fiber X-ray diffraction. Biomacromolecules 2007;8(7):2098-103. (Pubitemid 47104293)
26. Schaffazick SR, Siqueira IR, Badejo AS, et al. Incorporation in polymeric nanocapsules improves the antioxidant effect of melatonin against lipid peroxidation in mice brain and liver. Eur J Pharm Biopharm 2008;69:64-71.
27. Quintanar D, Allémann E, Doelker E, Fessi H. Preparation and characterization of nanocapsules from preformed polymers by a new process based on emulsification-diffusion technique. Pharm Res 1998;15:1056-62. (Pubitemid 28356923)
28. Nassar T, Rom A, Nyska A, Benita S. Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus a P-gp substrate drug. J Control Release 2009;133:77-84.
29. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 2010;75:1-18.
30. Mohanty AK, Misra M, Hinrichsen G. Biofibres, biodegradable polymer and biocomposites: an overview. Macromolecular Material and Engineering 2000;276-277(1):1-24.
31. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003;55:329-47. (Pubitemid 36297053)
32. Witschi C, Doelker E. Influence of the microencapsulation method and peptide loading on poly (lactic acid) and poly (lactic-coglycolic acid) degradation during in vitro testing. J Control Release 1998;51:327-41. (Pubitemid 28252884)
33. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-ecaprolactone microspheres and nanospheres: an overview. Int J Pharm 2004;278:1-23.
34. Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H, Couvreur P. Poly (alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Deliv Rev 2003;55(4):519-48. (Pubitemid 36423302)
35. Watnasirichaikul S, Rades T, Tucker LG, Davies NM. In vitro release of protein from poly (butylcyanoacrylate) nanocapsules with an aqueous core. Pharmacy and Pharmacology 2005;54:473-80.
36. Li S, Qian ZY, Liu XL, Liu XB. Preparation and in vitro release of poly (butyl cyanoacrylate) nanocapsules with an aqueous core containing bovine serum albumin. Acta Polymerica Sinica 2003;5:679-82. (Pubitemid 38055077)
37. Lambert G, Fattal E, Pinto-Alphandary H, Gulik A, Couvreur P. Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides. Pharm Res 2000;17(6):707-14. (Pubitemid 30670637)
38. Watnasirichaikul S, Rades T, Tucker LG, Davies NM. In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion. Pharmacy and Pharmacology 2002;54(4):473-80. (Pubitemid 34308489)
39. Quintanar D, Fessi H, Doelker E, Allemann E. Method for preparing vesicular nanocapsules. US Patent 6, 884, 438, Apr. 26, 2005.
40. Schaffazick SR, Pohlmann AR, Mezzalira G, Guterres SS. Development of nanocapsule suspensions and nanocapsule spray-dried powders containing melatonin. J Braz Chem Soc 2006;17(3):562-9. (Pubitemid 43824882)
41. Ashford M, Fell JT, Attwood D, Woodhead PJ. An in vitro investigation into the suitability of pH-dependent polymers for colonic targeting. Int J Pharm 1993;91:241-5. (Pubitemid 23159828)
42. Azarmi S, Farid J, Nokhodchi A, Bahari-Saravi SM, Valizadeh H. Thermal treating as a tool for sustained release of indomethacin from Eudragit RS and RL matrices. Int J Pharm 2002;246:171-7. (Pubitemid 35247989)
43. Kim Y K, Mukerjea R, Robyt J F. Controlled release of D-glucose from starch granules containing 29% free D-glucose and Eudragit L100-55 as a binding and coating agent. Carbohydrate Research 2010;345:1065-7.
44. Nogueira de Assis D, Furtado VC, Carneiro JM, Spangler M, Nascimento V. Release profiles and morphological characterization by atomic force microscopic and photon correlation spectroscopy of 99mTechnetium-fluconazole nanocapsules. Int J Pharm 2008;349:152-60.
45. Bilati U, Allemann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci 2005;24:67-75. (Pubitemid 40051288)
46. Fessi H, Puisieux F, Devissaguet J-Ph. Process for preparing a colloidal and disperse system in the shape of nanocapsules. European Patent 0, 274, 961, July 20, 1988.
47. Limayem Blouza I, Charcosset C, Sfar S, Fessi H. Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use. Int J Pharm 2006;325:124-31. (Pubitemid 44608215)
48. Stella B, Arpicco S, Rocco F, et al. Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules. Int J Pharm 2007;344:71-7 (Pubitemid 47464827)
49. Moraesa CM, Matosa AP, Paulaa E, Rosab AH, Fraceto LF. Benzocaine loaded biodegradable poly-(d, l-lactide-co-glycolide) nanocapsules factorial design and characterization. Materials Science and Engineering B 2009;165:243-6.
50. Mora-Huertasa CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm 2010;385:113-42.
51. Guinebretière S, Briançon S, Lieto J, Mayer C, Fessi H. Study of the emulsion-diffusion of solvent: preparation and characterization of nanocapsules. Drug Dev Res 2002;57:18-33 (Pubitemid 35375530)
52. Moinard-Chécot D, Chevalier Y, Briançon S, Beney L, Fessi H. Mechanism of nanocapsules formation by the emulsion-diffusion process. J Colloid Interface Sci 2008;317:458-68 (Pubitemid 350123539)
53. Joo HH, Lee HY, Guan YS, Kim JC. Colloidal stability and in vitro permeation study of poly (e-caprolactone) nanocapsules containing hinokitiol. J Industrial Engineering Chem 2008;14:608-13.
54. Lee MY, Min SG, Bourgeois S, Choi MJ. Development of a novel nanocapsule formulation by emulsion-diffusion combined with high hydrostatic pressure. J Microencapsul 2009;26(2):122-9.
55. Garti N. Double emulsions-scope, limitations and new achievements. Colloid Surf 1997;123-124:233-46. (Pubitemid 27292715)
56. Grigoriev D, Miller R. Mono-and multilayer covered drops as carriers. Curr Opin Colloid Interface Sci 2009;14:48-59.
57. Bilati U, Allémann E, Doelker E. Sonication Parameters for the Preparation of Biodegradable Nanocapsulesof Controlled Size by the Double Emulsion Method. Pharmaceutical Development and Technology 2003;8:1-9. (Pubitemid 36337473)
58. Bilati U, Allémann E, Doelker E. Poly (D, L-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method-processing and formulation issues for enhanced entrapment efficiency. Journal of microencapsulation 2005;22:205-14. (Pubitemid 40775308)
59. Lertsutthiwong P, Noomun K, Jongaroonngamsang N, Rojsitthisak P, Nimmannit U. Preparation of alginate nanocapsules containing turmeric oil. Carbohydr Polym 2008;74:209-14.
60. Lertsutthiwong P, Rojsitthisak P, Nimmannit U. Preparation of turmeric oil-loaded chitosan-alginate biopolymeric nanocapsules. Materials Science and Engineering C 2009;29:856-60.
61. Krause HJ, Rohdewald P. Preparation of gelatin nanocapsules and their pharmaceutical characterization. Pharm Res 1985;5:239-43. (Pubitemid 15228742)
62. Lutter S, Koetz J, Tiersch B, Boschetti de Fierro A, Abetz V. Formation of gold nanoparticles in triblock terpolymer-modified inverse microemulsions. Colloids Surf A Physicochem Eng Asp 2008;329:160-76.
63. Gander B, Blanco-Príeto MJ, Thomasin C, Wandrey C, Hunkeler D. Coacervation and phase separation. In: Swarbrick J, Boylan JC (Eds.), Encyclopedia of pharmaceutical technology. Marcel Dekker, New York, 2002;481-96.
64. Radtchenko IL, Sukhorukov GB, Möhwald H. Incorporation of macromolecules into polyelectrolyte micro-and nanocapsules via surface controlled precipitation on colloidal particles. Colloid Surf A 2002;202:127-33. (Pubitemid 34203543)
65. 30}-embedded hybrid nanocapsules. J Colloid Interface Sci 2009;330(2):488-92.
66. Su YL, Li C. A novel multilayer Wlm with temperature dependent solubilization property. Reactive & Functional Polymers 2007;67:233-40. (Pubitemid 46205337)
67. Read ES, Armes SP. Recent advances in shell cross-linked micelles. Chem Commun 2007;29:3021-35. (Pubitemid 47087703)
68. Chen DY, Jiang M. Strategies for constructing polymeric micelles and hollow spheres in solution via specific intermolecular interactions. Acc Chem Res 2005;38:494-502. (Pubitemid 40994872)
69. Ievins AD, Moughton AO, O'Reilly RK. Synthesis of hollow responsive functional nanocages using a non covalently connected micelle strategy. Macromolecules 2008;41:3571-8.
70. Moughton AO, O'Reilly RK. Noncovalently connected micelles, nanoparticles, and metal-Functionalized nanocages using supramolecular self-Assembly. J Am Chem Soc 2008;130(27):8714-25. (Pubitemid 351962505)
71. Zhang Q, Remsen EE, Wooley KL. Shell crosslinked nanoparticles containing hydrolytically degradable crystalline core domains. J Am Chem Soc 2000;122(15):3642-51. (Pubitemid 30233434)
72. Huang H, Remsen EE, Kowalewski T, Wooley KL. Nanocages derived from shell cross-linked micelle templates. J Am Chem Soc 1999;121(15):3805-6. (Pubitemid 29200302)
73. Sanji T, Nakatsuka Y, Ohnishi S, Sakurai H. Preparation of nanometer-sized hollow particles by photochemical degradation of polysilane shell cross-linked micelles and reversible encapsulation of guest molecules. Macromolecules 2000;33(23):8524-6. (Pubitemid 32069905)
74. Stewart S, and Liu GJ. Hollow nanospheres from polyisopreneblock-poly (2-cinnamoylethyl methacrylate)-block-poly (tert-butyl acrylate). Chem Mater 1999;11(4):1048-54.
75. Turner JL, Chen ZY, Wooley KL. Regiochemical functionalization of a nanoscale cage-like structure: robust core-shell nanostructures crafted as vessels for selective uptake and release of small and large guests. J Control Release 2005;109:189-202. (Pubitemid 41737263)
76. Wang YJ, Angelatos AS, Caruso F. Template Synthesis of Nanostructured Materials via Layer-by-Layer Assembly. Chem Mater 2008;20(3):848-58. (Pubitemid 351315683)
77. Schneider G, Decher G. From functional core/shell nanoparticles prepared via layer-by-layer deposition to empty nanospheres. Nano Lett 2004;4(10):1833-9.
78. Duan HW, Kuang M, Zhang G, Wang DY, Kurth DG, Möhwald H. pH-Responsive capsules derived from nanocrystal templating. Langmuir 2005;21(24):11495-9. (Pubitemid 41775122)
79. Chen Y, Cho J, Young A, Taton TA. Enhanced stability and bioconjugation of photo-cross-linked polystyrene-shell, au-core nanoparticles. Langmuir 2007;23(14):7491-7. (Pubitemid 47116407)
80. Mandal TK, Fleming MS, Walt DR. Production of hollow polymeric microspheres by surface confined living radical polymerization on silica templates. Chem Mater 2000;12:3481-7. (Pubitemid 32063960)
81. Marinakos SM, Anderson MF, Ryan JA, Martin LD, Feldheim DL. Encapsulation, permeability, and cellular uptake characteristics of hollow nanometer-sized conductive polymer capsules. J Phys Chem B 2001;105:8872-6. (Pubitemid 35338762)
82. Meier W. Polymer nanocapsules. Chem Soc Rev 2000;29:295-303.
83. Vriezema DM, Aragonès MC, Elemans JAAW, Cornelissen JJLM, Rowan AE, Nolte RJM. Self-Assembled Nanoreactors. Chem Rev 2005;105(4):1445-89. (Pubitemid 40596870)
84. Krol S, Diaspro A, Cavalleri O, et al. Nanocapsules a novel tool for medicine and science. NATO Science Series II: Mathematics, Physics and Chemistry 2005;152:439-46.
85. Radtchenko IL, Sukhorukov GB, Möhwald H. A novel method for encapsulation of poorly water-soluble drugs: precipitation in polyelectrolyte multilayer shells. Int J Pharm 2002;242:219-23.
86. Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res 2009;26(5):1025-58.
87. Aulton ME. In: Particle-size Analysis; Staniforth J, ED. Pharmaceutics: The science of dosage form design. 2rd Ed. Churchill Livingstone: London 2002;160-2.
88. Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm 2008;69:1-9. (Pubitemid 351467152)
89. Vanderlinde WE, Ballarotto VW. Microscopy at the nanoscale. In: proceedings of the 30th international symposium for testing and failure analysis; 2004 Nov. 14-18; Worcester, Boston, Massachusetts, USA 2004; pp. 1-8.
90. Adeli M, Mirab N, Zabihi F. Nanocapsules based on carbon nanotubes-graft-polyglycerol hybrid materials. Nanotechnology 2009;20(48):485-603.
91. Duclairoir C, Nakache E. Polymer nanoparticle characterization in aqueous suspensions. Int J Polym Anal Charact 2002;7:284-313.
92. Ravi Kumar MN, Bakowsky U, Lehr CM. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials 2004;25:1771-7. (Pubitemid 38102253)
93. Boukari H, Sackett DL. Fluorescence Correlation Spectroscopy and its application to the characterization of molecular properties and interactions. Methods in Cell Biology 2008;84:659-78.
94. Weyermanna J, Lochmanna D, Georgens C, et al. Physicochemical characterisation of cationic polybutylcyanoacrylat-nanoparticles by fluorescence correlation spectroscopy. European Journal of Pharmaceutics and Biopharmaceutics 2004;58:25-35. (Pubitemid 38781001)
95. Schimp ME, Caldwell K, Giddings JC. Field-Flow Fractionation Handbook. Wiley-Interscience New York, 2000.
96. Dulog L, Schauer T. Field-flow fractionation for particle size determination. Prog Org Coat 1996, 28:25-31. (Pubitemid 126405282)
97. Carpinoa F, Zborowski M, Williams PS. Quadrupole magnetic field-flow fractionation: A novel technique for the characterization of magnetic nanoparticles. J Magn Magn Mater 2007, 311:383-7. (Pubitemid 46400984)
98. Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mäder K. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release 2004;95:217-27. (Pubitemid 38230037)
99. Liu FK, Lin YY, Wu CH. Highly efficient approach for characterizing nanometer-sized gold particles by capillary electrophoresis. Analytica Chimica Acta 2005;528:249-54.
100. Fernandez-Urrusuno R, Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm Res 1999;16(10):1576-81. (Pubitemid 29510555)
101. 1H NMR spectroscopy. Biomaterials 1997;18(1):27.
102. Rübe A, Hause G, Mäder K, Kohlbrecher J. Core-shell structure of miglyol/poly (d, l-lactide)/poloxamer nanocapsules studied by small angle neutron scattering. J Control Release 2005;107:244-52. (Pubitemid 41316287)
103. Poletto FS, Jäger E, Cruz L, Pohlmann AR, Guterres SS. The effect of polymeric wall on the permeability of drug-loaded nanocapsules. Mater Sci Eng C 2008;28:472-8. (Pubitemid 351417799)
104. Zili Z, Sfar S, Fessi H. Preparation and characterization of poly-ecaprolactone nanoparticles containing griseofulvin. Int J Pharm 2005;294:261-7. (Pubitemid 40462340)
105. Kohler N, Sun C, Wang J, Zhang MQ, et al. Methotrexatemodified superparamagnetic nanoparticles and their intracellular up take into human cancer cells. Langmuir 2005;21(19):8858-64. (Pubitemid 41396647)
106. Jain TK, Morales MA, Sahoo SK, Leslie-Relecky DL, Labhasetwar V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharmacol 2005;2(3):194-205. (Pubitemid 40917416)
107. Nishioka Y, Yoshino H. Lymphatic targeting with nanoparticulate system. Adv Drug Deliv Rev 2001;47:55-64. (Pubitemid 32209232)
108. Nishioka Y, Mizobe M, Yoshino H, et al. Evaluation of the lymphspecific delivery using polyisobutylcyanoacrylate nanocapsules. Abstracts of the 118th Annual Meeting of the Pharmaceutical Society of Japan; 1998 Mar. 31-Apr. 2; Kyoto, Japan. Tokyo: The Pharmaceutical Society of Japan 1998;4:51.
109. Wang Z, Paul C. A nanocapsular combinatorial sequential drug delivery system for antiangiogenesis and anticancer activities. Biomaterials 2010;31:7115-23.
110. Bernardi A, Braganhol E, Jäger E, et al. Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model. Cancer Letters 2009;281:53-63.
111. Bernardi A, Frozza RL, Jäger E, et al. Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: An in vitro study. Eur J Pharmacol 2008;586:24-34.
112. Silva Santos NP, Nascimento SC, Wanderley MSO, et al. Nanoencapsulation of usnic acid: An attempt to improve antitumour activity and reduce hepatotoxicity. Eur J Pharm Biopharm 2006;64:154-60. (Pubitemid 44291998)
113. Pietkiewicz J, Zielinska K, Saczko J, Kulbacka J, Majkowski M, Wilk KA. New approach to hydrophobic cyanine-type photosensitizer delivery using polymeric oil-cored nanocarriers: Hemolytic activity, in vitro cytotoxicity and localization in cancer cells. European Journal of Pharmaceutical Sciences 2010;39:322-35.
114. Bisht S, Feldmann G, Soni S, et al. Polymeric nanoparticleencapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnology 2007;5(3):1-18.
115. Jeong YI, Na HS, Seo DH, et al. Ciprofloxacin-encapsulated poly (d, l-lactide-co-glycolide) nanoparticles and its antibacterial activity. Int J Pharm 2008;352:317-23.
116. 99mTechnetium- HMPAO: Release properties and microscopy and photon correlation spectroscopy. Eur J Pharm Sci 2008;33:42-51.
117. Surassmo S, Min SG, Bejrapha P, Choi MJ. Effects of surfactants on the physical properties of capsicum oleoresin-loaded nanocapsules formulated through the emulsion-diffusion method. Food Research International 2010;43:8-17.
118. Beck RCR, Pohlmann AR, Hoffmeister C, et al. Dexamethasoneloaded nanoparticle-coated microparticles: Correlation between in vitro drug release and drug transport across Caco-2 cell monolayers. Eur J Pharm Biopharm 2007;67:18-30. (Pubitemid 46991337)
119. Sias FL, Silveiraa RP, Deboni AM, et al. Nanocapsule@xerogel microparticles containing sodium diclofenac: A new strategy to control the release of drugs. Int J Pharm 2008;358:292-5.
120. Honga CC, Wanga CY, Pengb KT, Chuc IM. A microfluidic chip platform with electrochemical carbon nanotube electrodes for preclinical evaluation of antibiotics nanocapsules. Biosens Bioelectron 2011;26:3620-6.
121. Zheng C, Qiu L, Zhu K. Novel polymersomes based on amphiphilic graft polyphosphazenes and their encapsulation of watersoluble anti-cancer drug. Polymer 2009;50:1173-7
122. Shim J, Kang HS, Park WS, Han SH, Kim J, Chang IS. Transdermal delivery of mixnoxidil with block copolymer nanoparticles. J Control Rel 2004;97:477-84. (Pubitemid 38802949)
123. Teixeiraa Z, Zanchetta B, Melo BAG, et al. Retinyl palmitate flexible polymeric nanocapsules: Characterization and permeation studies. Colloids Surf B: Biointerfaces 2010;81:374-80.
124. Miyazaki S, Takahashi A, Kubo W, Bachynsky J, Löbenberg R. Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. J Pharm Pharmaceut Sci 2003;6(2):238-45.
125. Alves MP, Scarrone AL, Santos M, Pohlmann AR, Guterres SS. Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int J Pharm 2007;341:215-20. (Pubitemid 47088101)
126. Ourique AF, Melero A, Bona da Silva C, et al. Improved photostability and reduced skin permeation of tretinoin: Development of a semisolid nanomedicine. Eur J Pharm Biopharm 2011.
127. Zhang Q, Yie GQ, Li Y, Yang QS, Nagai T. Studies on the cyclosporin A loaded stearic acid nanoparticles. Int J Pharm 2000;200(2):153-9. (Pubitemid 30364902)
128. Sosnik A, Carcaboso ÁM, Glisoni RJ, Moretton MA, Chiappetta DA. New old challenges in tuberculosis: Potentially effective nanotechnologies in drug delivery. Adv Drug Deliv Rev 2010;62:547-59.
129. Pandey R, Zahoor A, Sharma S, Khuller GK. Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis. Tuberculosis 2003;83(6):373-8. (Pubitemid 37464042)
130. Pandey R, Khuller GK. Oral nanoparticle-based antituberculosis drug delivery to the brain in an experimental model. J Antimicrob Chemother 2006;57:1146-52. (Pubitemid 44644418)
131. Ahmad Z, Pandey R, Sharma S, Khuller GK. Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses. International Journal of Antimicrobial Agents 2006;27:409-16.
132. Kisich KO, Gelperina S, Higgins MP, et al. Encapsulation of moxifloxacin within poly (butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis. Int J Pharm 2007;345:154-62. (Pubitemid 350087550)
133. Rappuoli R, Covacci A. Reverse vaccinology and genomics. Science 2003;302(5645):602. (Pubitemid 37310907)
134. Singh M, Briones M, Ott G, O'Hagan D. Cationic microparticles: a potent delivery system for DNA vaccines. Proc Natl Acad Sci USA 2000;97(2):811-6. (Pubitemid 30070392)
135. Otten G, Schaefer M, Doe B, et al. Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine 2004;22:2489-93. (Pubitemid 38757348)
136. Dudley ME, Wunderlich JR, Robbins PF, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor Lymphocytes. Science 2002;298:850-4. (Pubitemid 35231542)
137. Couvreur P, Barratt G, Fattal E, Legrand P, Vauthier C. Nanocapsule technology: a review. Crit Rev Ther Drug Carrier Syst 2002;19:99-134.
138. Damge C, Hillairebuys D, Puech R, et al. Effects of orallyadministered insulin nanocapsules in normal and diabetic dogs. Diabetes Nutr Metab 1995;8(1):3-9.
139. Aboubakar M, Puisieux F, Couvreur P, et al. Physico-chemical characterization of insulin-loaded poly (isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. Int J Pharm 1999;183:63-6. (Pubitemid 29248830)
140. Damge C, Vonderscher J, Marbach P, Pinget M. Poly (alkylcyanoa-crylate) nanocapsules as a delivery system in the rat for octreotide, a long-acting somatostatin analogue. J Pharm Pharmacol 1997;49:949-54. (Pubitemid 27478385)
141. Shu SJ, Sun CY, Zhang XG, Wu ZM, Wang Z, Li CX. Hollow and degradable polyelectrolyte nanocapsules for protein drug delivery. Acta Biomater 2010;6:210-7.
142. Labhasetwar V. Nanoparticles for drug delivery. Pharmaceutical News 1997;4:28-31.
143. Zou WW, Liu CX, Chen ZJ, Zhang N. Studies on bioadhesive PLGA nanoparticles: a promising gene delivery system for efficient gene therapy to lung cancer. Int J Pharm 2009;370:187-91.
144. Cui ZR, Mumpe RJ. Plasmid DNA-entrapped nanoparticles engineered from microemulsion precursors: in vitro and in vivo evaluation. Bioconjug Chem 2002;13(6):1319-27.
145. Li YP, Ogris M, Wagner E, Pelisek J, Rüffer M. Nanoparticles bearing polyethyleneglycol coupled transferrin as gene carriers: preparation and in vitro evaluation. Int J Pharm 2003;259:93-101. (Pubitemid 36638557)
146. Mao HQ, Roy K, Troung-Le VL, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Rel 2001;70:399-421. (Pubitemid 32155463)
147. Santander-Ortega MJ, Peula-García JM, Goycooleab FM, Ortega-Vinuesa JL. Chitosan nanocapsules: effect of chitosan molecular weight and acetylation degree on electrokinetic behaviour and collo-idal stability. Colloids Surf B: Biointerfaces 2011;82:571-80.
148. Whelan J, Writer F. Nanocapsules for controlled drug delivery. Drug Discov Today 2001;6(23):1183-4. (Pubitemid 33101885)
149. Barratt GM. Therapeutic applications of colloidal drug carriers. Pharm Sci Technolo Today 2000;3(5):163-71. (Pubitemid 30261519)